ReviewFrontiers in immunology2026

MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma.

Huiwen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.